215 related articles for article (PubMed ID: 25821749)
1. Transition zone prostate specific antigen density improves prostate cancer detection in Iranian men.
Nowroozi M; Ayati M; Jamshidian H; Arbab A; Ghorbani H; Amini E; Hakima H; Salehi S; Ghadian A
Nephrourol Mon; 2015 Mar; 7(2):e26752. PubMed ID: 25821749
[TBL] [Abstract][Full Text] [Related]
2. Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml.
Chang TH; Lin WR; Tsai WK; Chiang PK; Chen M; Tseng JS; Chiu AW
BMC Urol; 2020 Oct; 20(1):151. PubMed ID: 33028274
[TBL] [Abstract][Full Text] [Related]
3. Transition zone PSA density improves the prostate cancer detection rate both in PSA 4.0-10.0 and 10.1-20.0 ng/ml in Chinese men.
Tang P; Du W; Xie K; Deng X; Fu J; Chen H; Yang W
Urol Oncol; 2013 Aug; 31(6):744-8. PubMed ID: 21868261
[TBL] [Abstract][Full Text] [Related]
4. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
Akduman B; Alkibay T; Tuncel A; Bozkirli I
Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
[TBL] [Abstract][Full Text] [Related]
5. Transition Zone Prostate-specific Antigen Density Could Better Guide the Rebiopsy Strategy in Men With Prostate Inflammation at Initial Biopsy.
Amini E; Pishgar F; Ayati M; Jamshidian H; Arbab A; Gooshe M; Nowroozi MR
Urology; 2015 Nov; 86(5):985-90. PubMed ID: 26284593
[TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
7. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
8. Assessment of serum level of prostate-specific antigen adjusted for the transition zone volume in early detection of prostate cancer.
Ferreira MD; Koff WJ
Int Braz J Urol; 2005; 31(2):137-45; discussion 146. PubMed ID: 15877833
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer screening in Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
[TBL] [Abstract][Full Text] [Related]
10. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ
Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
[TBL] [Abstract][Full Text] [Related]
11. PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL.
Djavan B; Zlotta A; Kratzik C; Remzi M; Seitz C; Schulman CC; Marberger M
Urology; 1999 Sep; 54(3):517-22. PubMed ID: 10475364
[TBL] [Abstract][Full Text] [Related]
12. Comparison of PSA-density of the transition zone and whole gland for risk stratification of men with suspected prostate cancer: A retrospective MRI-cohort study.
Schneider AF; Stocker D; Hötker AM; Eberli D; Rupp NJ; Donati OF; Becker AS
Eur J Radiol; 2019 Nov; 120():108660. PubMed ID: 31546123
[TBL] [Abstract][Full Text] [Related]
13. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
[TBL] [Abstract][Full Text] [Related]
14. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
15. Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.
Reissigl A; Horninger W; Fink K; Klocker H; Bartsch G
Cancer; 1997 Nov; 80(9):1818-29. PubMed ID: 9351555
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prostate specific antigen density and transrectal ultrasonography-guided biopsies in 100 consecutive patients with a negative digital rectal examination and intermediate serum prostate specific antigen levels.
Tarcan T; Ozveri H; Biren T; Türkeri L; Akdas A
Int J Urol; 1997 Jul; 4(4):362-7. PubMed ID: 9256325
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer screening in the Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur J Cancer; 2000 Jun; 36(10):1322-35. PubMed ID: 10882875
[TBL] [Abstract][Full Text] [Related]
19. [Retrospective evaluation of PSA density for selection of biopsy candidates with prostate specific antigen in the gray zone].
Tochigi T; Kawamura S; Numahata K; Tokuyama S; Kuwahara M; Horaguchi T; Satou S
Nihon Hinyokika Gakkai Zasshi; 2001 Sep; 92(6):609-14. PubMed ID: 11593702
[TBL] [Abstract][Full Text] [Related]
20. An artificial neural network to predict the outcome of repeat prostate biopsies.
Remzi M; Anagnostou T; Ravery V; Zlotta A; Stephan C; Marberger M; Djavan B
Urology; 2003 Sep; 62(3):456-60. PubMed ID: 12946746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
